Your browser is no longer supported. Please, upgrade your browser.
Settings
CLB Core Laboratories N.V. daily Stock Chart
CLB [NYSE]
Core Laboratories N.V.
Index- P/E- EPS (ttm)-1.80 Insider Own0.20% Shs Outstand44.47M Perf Week-12.61%
Market Cap739.99M Forward P/E18.58 EPS next Y0.87 Insider Trans1.41% Shs Float43.97M Perf Month-28.29%
Income-79.70M PEG- EPS next Q0.16 Inst Own- Short Float10.42% Perf Quarter-20.76%
Sales598.10M P/S1.24 EPS this Y17.80% Inst Trans-3.17% Short Ratio8.06 Perf Half Y57.41%
Book/sh1.40 P/B11.54 EPS next Y9.86% ROA-11.30% Target Price21.93 Perf Year-65.20%
Cash/sh0.46 P/C35.24 EPS next 5Y2.80% ROE-64.60% 52W Range6.68 - 49.22 Perf YTD-57.13%
Dividend0.04 P/FCF37.95 EPS past 5Y-18.20% ROI22.60% 52W High-69.08% Beta3.07
Dividend %0.25% Quick Ratio1.50 Sales past 5Y-9.20% Gross Margin24.80% 52W Low127.84% ATR1.08
Employees4300 Current Ratio1.90 Sales Q/Q-31.50% Oper. Margin-9.90% RSI (14)25.77 Volatility5.91% 5.52%
OptionableYes Debt/Eq4.62 EPS Q/Q-129.60% Profit Margin-13.40% Rel Volume0.52 Prev Close16.15
ShortableYes LT Debt/Eq4.62 EarningsJul 22 AMC Payout- Avg Volume568.20K Price15.22
Recom3.00 SMA20-19.45% SMA50-28.78% SMA200-36.87% Volume162,642 Change-5.76%
Jul-16-20Downgrade Scotiabank Sector Outperform → Sector Perform
Apr-13-20Upgrade Scotiabank Sector Perform → Sector Outperform $13
Mar-09-20Downgrade Evercore ISI Outperform → In-line
Mar-09-20Downgrade BofA/Merrill Buy → Underperform
Jan-31-20Reiterated Cowen Market Perform $39 → $36
Jan-30-20Resumed Johnson Rice Buy $47
Jan-14-20Initiated Bernstein Mkt Perform
Jan-02-20Downgrade Stifel Buy → Hold $50 → $40
Dec-31-19Reiterated Cowen Market Perform $42 → $39
Jul-10-19Upgrade BofA/Merrill Neutral → Buy $63
Feb-25-19Upgrade Tudor Pickering Hold → Buy
Dec-19-18Downgrade Credit Suisse Outperform → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-16-18Upgrade Guggenheim Neutral → Buy
Nov-01-18Upgrade ABN Amro Sell → Buy
Oct-29-18Reiterated Cowen Market Perform $100 → $90
Oct-18-18Initiated BofA/Merrill Neutral
Oct-10-18Initiated Wolfe Research Underperform
Sep-19-18Initiated Morgan Stanley Equal-Weight $125
Sep-04-18Initiated Edward Jones Buy
Sep-25-20 08:19AM  
Sep-22-20 04:15PM  
Sep-21-20 02:29PM  
Sep-16-20 02:31PM  
Sep-08-20 11:52AM  
Sep-01-20 09:11AM  
Aug-21-20 11:30AM  
Aug-20-20 06:42PM  
Aug-11-20 11:40AM  
Aug-10-20 08:19AM  
Jul-28-20 02:06PM  
08:21AM  
Jul-23-20 04:01PM  
12:34PM  
Jul-22-20 06:35PM  
05:15PM  
Jul-18-20 10:59AM  
Jul-17-20 04:15PM  
Jul-15-20 12:31PM  
Jun-27-20 09:11PM  
Jun-25-20 12:04PM  
Jun-23-20 06:42PM  
Jun-15-20 02:09PM  
Jun-12-20 06:39PM  
Jun-10-20 07:37PM  
May-29-20 10:33AM  
May-22-20 11:30AM  
May-05-20 03:35PM  
Apr-30-20 08:50AM  
Apr-29-20 02:46PM  
Apr-28-20 04:15PM  
02:18PM  
Apr-23-20 07:10AM  
Apr-22-20 06:25PM  
05:05PM  
Apr-21-20 08:45PM  
Apr-18-20 09:35AM  
Apr-17-20 09:47AM  
Apr-15-20 12:31PM  
Apr-14-20 09:47AM  
Apr-13-20 02:00PM  
Apr-12-20 08:24AM  
Mar-27-20 04:15PM  
Mar-26-20 04:05PM  
Mar-20-20 06:22AM  
Mar-16-20 05:40PM  
Mar-11-20 07:15AM  
Mar-09-20 05:07PM  
Feb-28-20 11:31AM  
07:11AM  
Feb-08-20 02:29PM  
Feb-06-20 06:24AM  
Jan-31-20 10:29AM  
Jan-29-20 08:15PM  
05:35PM  
Jan-22-20 04:13PM  
12:31PM  
Jan-16-20 07:02AM  
Jan-15-20 09:04AM  
Jan-14-20 04:20PM  
Jan-08-20 02:01PM  
06:56AM  
Jan-07-20 09:07AM  
Jan-03-20 10:51AM  
Dec-31-19 09:29AM  
09:27AM  
07:06AM  
Dec-30-19 05:41PM  
05:35PM  
05:31PM  
Dec-19-19 07:44AM  
Dec-12-19 09:50AM  
Nov-26-19 05:45AM  
Nov-22-19 09:31AM  
Oct-31-19 07:21AM  
Oct-29-19 05:29AM  
Oct-25-19 11:50AM  
Oct-24-19 02:05PM  
Oct-23-19 06:35PM  
05:15PM  
Oct-22-19 10:34AM  
Oct-16-19 11:43AM  
10:32AM  
Oct-13-19 07:57AM  
Oct-08-19 04:05PM  
Sep-28-19 09:43AM  
Sep-24-19 04:34PM  
Sep-16-19 02:00AM  
Sep-10-19 08:01AM  
Sep-07-19 07:32AM  
Sep-06-19 09:17PM  
Aug-28-19 07:47AM  
Aug-25-19 11:03AM  
Aug-23-19 09:31AM  
07:50AM  
Aug-17-19 12:11PM  
Aug-10-19 06:32AM  
Aug-05-19 10:42AM  
Jul-31-19 01:04PM  
Jul-30-19 09:36PM  
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daniels KevinCAO & TreasurerJul 01Option Exercise0.001050749Jul 02 04:06 PM
Sodderland Jan WillemDirectorMay 07Buy17.0760010,2427,852May 07 04:05 PM
Straughen MichaelDirectorApr 01Option Exercise0.002,17704,433Apr 02 02:58 PM
van Kempen Margaret AnnDirectorApr 01Option Exercise0.002,17706,575Apr 02 02:59 PM
Sodderland Jan WillemDirectorApr 01Option Exercise0.002,17708,330Apr 02 02:56 PM
Hill Christopher ScottSVP & CFOApr 01Option Exercise0.0053015,132Apr 02 02:56 PM
Daniels KevinCAO & TreasurerApr 01Option Exercise0.00700676Apr 02 02:54 PM
Carnes Martha Z.DirectorApr 01Option Exercise0.002,17706,377Apr 02 02:54 PM
Bruno LawrencePresident & COOApr 01Option Exercise0.00100010,899Apr 02 02:52 PM
Barnett Gregory BarryDirectorApr 01Option Exercise0.002,177015,177Apr 02 02:51 PM
GOLDMAN SACHS GROUP INC10% OwnerApr 01Buy9.346766,3134,640,900May 19 12:06 PM
Daniels KevinCAO & TreasurerMar 01Option Exercise0.001200660Mar 03 04:12 PM
Bruno LawrencePresident & COOFeb 03Buy34.863,000104,57910,799Feb 04 10:57 AM
Elvig Mark FVP,Counsel & SecretaryJan 02Sale37.9360022,75911,035Jan 03 04:09 PM
Elvig Mark FVP,Counsel & SecretaryDec 31Option Exercise0.002,400013,052Jan 03 04:09 PM
Hill Christopher ScottSVP & CFODec 31Option Exercise0.002,400016,024Jan 03 04:09 PM
DEMSHUR DAVID MChief Executive OfficerDec 31Option Exercise0.0059,1000385,118Jan 03 04:07 PM
Bruno LawrencePresident & COODec 31Option Exercise0.002,40008,744Jan 03 04:08 PM
Daniels KevinCAO & TreasurerDec 01Option Exercise0.001400594Dec 03 03:00 PM